An EORTC Gastrointestinal Group phase II evaluation of epirubicin combined with ifosfamide in advanced adenocarcinoma of the pancreas. EORTC Gastrointestinal Group

Eur J Cancer Clin Oncol. 1989 Jul;25(7):1119-20. doi: 10.1016/0277-5379(89)90398-2.
No abstract available

MeSH terms

  • Adenocarcinoma / drug therapy*
  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Drug Evaluation
  • Epirubicin / administration & dosage
  • Female
  • Humans
  • Ifosfamide / administration & dosage
  • Male
  • Middle Aged
  • Pancreatic Neoplasms / drug therapy*

Substances

  • Epirubicin
  • Ifosfamide